EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes

Sarah Reid, Johanna K Sandling iD, Pascal Pucholt, Ahmed Sayadi, Martina Frodlund, Karoline Lerang, Iva Gunnarsson, Andreas Jönsen, Ann-Christine Syvänen, Øyvind Molberg, Solbritt Rantapää-Dahlqvist iD, Anna Rudin iD und 5 weitere

Journal of Internal Medicine · 2026

DOI: 10.1111/joim.70040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Sarah Reid und 16 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Genetic Predisposition to Disease. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Swedish Society for Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic lupus erythematosus (SLE) is an autoimmune disease with a heterogenous clinical picture. This study aimed to link genetic SLE predisposition with relevant clinical manifestations.

Method

Datasets best corresponding to the 11 American College of Rheumatology 1982 (ACR‐82) classification criteria for SLE in a large, public database (FinnGen consortium, >218,000 individuals) were identified. Mendelian randomization analysis was conducted to evaluate the effect of a high genetic SLE predisposition on each manifestation. Next, validation was conducted in a clinical SLE cohort comprising 1487 genotyped Scandinavian patients with detailed clinical data. Based on the public datasets, genetic risk scores (GRSs) for each relevant manifestation were constructed for each patient. Associations between each GRS and the corresponding ACR‐82 criterion were evaluated using logistic regression.

Results

In the FinnGen biobank, the cumulative effect of the 57 SLE risk SNPs was associated with an increased risk of rosacea, OR 1.09 (1.03–1.16), polyarthropathies, OR 1.10 (1.06–1.14), pleural effusions, OR 1.09 (1.04–1.14), and hemolytic anemia, OR 1.32 (1.10–1.58). In the clinical cohort, 5 of the 11 GRSs generated from the public datasets were associated with their corresponding ACR‐82 criterion: arthritis, OR 1.15 (1.02–1.31), renal disorder, OR 1.15 (1.04–1.29), neurologic disorder, OR 1.24 (1.04–1.47), hematologic disorder, OR 1.12 (1.00–1.24), and immunologic disorder, OR 1.37 (1.22–1.56).

Conclusion

The findings demonstrate that known SLE risk gene variants play a role in the development of at least half of the ACR‐82 criteria for SLE, indicating a future possibility of using genetics to predict a variety of disease sub‐phenotypes in SLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicGenetic Predisposition to DiseaseHumansFemaleRisk FactorsMalePolymorphism, Single NucleotideAdultMiddle AgedMendelian Randomization Analysis

Stichwörter der Autor:innen

FinnGen consortiumMendelian randomizationautoimmunitydisease subtypesgenetic risk scoresystemic lupus erythematosus

Autor:innen und Institutionen

  • Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden.
  • Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
  • Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.

ORCID-Profile: Johanna K Sandling, Solbritt Rantapää-Dahlqvist, Anna Rudin, Christopher Sjöwall, Elisabet Svenungsson, Lars Rönnblom, Dag Leonard

Förderung

  • the Swedish Society for Medical Research

Zitieren

APA

Reid, S., Sandling, J. K., Pucholt, P., Sayadi, A., Frodlund, M., Lerang, K., Gunnarsson, I., Jönsen, A., Syvänen, A. C., Molberg, Ø., Rantapää-Dahlqvist, S., Rudin, A., Sjöwall, C., Svenungsson, E., Bengtsson, A. A., Rönnblom, L., & Leonard, D. (2026). Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes. Journal of Internal Medicine. https://doi.org/10.1111/joim.70040

Vancouver

Reid S, Sandling JK, Pucholt P, Sayadi A, Frodlund M, Lerang K, et al. Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes. Journal of Internal Medicine. 2026. doi:10.1111/joim.70040

BibTeX
@article{Reid2026,
  author = {Reid, Sarah and Sandling, Johanna K and Pucholt, Pascal and Sayadi, Ahmed and Frodlund, Martina and Lerang, Karoline and Gunnarsson, Iva and Jönsen, Andreas and Syvänen, Ann-Christine and Molberg, Øyvind and Rantapää-Dahlqvist, Solbritt and Rudin, Anna and Sjöwall, Christopher and Svenungsson, Elisabet and Bengtsson, Anders A and Rönnblom, Lars and Leonard, Dag},
  title = {Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes},
  journal = {Journal of Internal Medicine},
  year = {2026},
  doi = {10.1111/joim.70040}
}
Kostenlos starten →